AMGEN INC (1AMGN.MI) Stock Fundamental Analysis
Europe - BIT:1AMGN - US0311621009 - Common Stock
293.45 EUR
+36.9 (+14.38%)
Overall 1AMGN gets a fundamental rating of 5 out of 10. We evaluated 1AMGN against 74 industry peers in the Biotechnology industry. While 1AMGN belongs to the best of the industry regarding profitability, there are concerns on its financial health. 1AMGN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year 1AMGN was profitable.
In the past year 1AMGN had a positive cash flow from operations.
In the past 5 years 1AMGN has always been profitable.
Each year in the past 5 years 1AMGN had a positive operating cash flow.
1.2 Ratios
1AMGN's Return On Assets of 7.53% is amongst the best of the industry. 1AMGN outperforms 85.33% of its industry peers.
1AMGN has a Return On Equity of 89.11%. This is amongst the best in the industry. 1AMGN outperforms 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 14.12%, 1AMGN belongs to the best of the industry, outperforming 90.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1AMGN is in line with the industry average of 12.80%.
The 3 year average ROIC (13.04%) for 1AMGN is below the current ROIC(14.12%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.53% | ||
| ROE | 89.11% | ||
| ROIC | 14.12% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
1.3 Margins
1AMGN has a Profit Margin of 18.96%. This is amongst the best in the industry. 1AMGN outperforms 86.67% of its industry peers.
1AMGN's Profit Margin has declined in the last couple of years.
1AMGN has a Operating Margin of 31.30%. This is amongst the best in the industry. 1AMGN outperforms 90.67% of its industry peers.
1AMGN's Operating Margin has declined in the last couple of years.
1AMGN has a better Gross Margin (69.71%) than 65.33% of its industry peers.
In the last couple of years the Gross Margin of 1AMGN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.3% | ||
| PM (TTM) | 18.96% | ||
| GM | 69.71% |
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1AMGN is creating some value.
1AMGN has more shares outstanding than it did 1 year ago.
1AMGN has less shares outstanding than it did 5 years ago.
1AMGN has a better debt/assets ratio than last year.
2.2 Solvency
1AMGN has a debt to FCF ratio of 4.94. This is a neutral value as 1AMGN would need 4.94 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.94, 1AMGN belongs to the top of the industry, outperforming 81.33% of the companies in the same industry.
A Debt/Equity ratio of 7.24 is on the high side and indicates that 1AMGN has dependencies on debt financing.
1AMGN has a Debt to Equity ratio of 7.24. This is in the lower half of the industry: 1AMGN underperforms 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.24 | ||
| Debt/FCF | 4.94 | ||
| Altman-Z | N/A |
ROIC/WACC1.5
WACC9.43%
2.3 Liquidity
A Current Ratio of 1.31 indicates that 1AMGN should not have too much problems paying its short term obligations.
1AMGN has a worse Current ratio (1.31) than 66.67% of its industry peers.
A Quick Ratio of 0.98 indicates that 1AMGN may have some problems paying its short term obligations.
The Quick ratio of 1AMGN (0.98) is worse than 69.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.31 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 17.26% over the past year.
Measured over the past 5 years, 1AMGN shows a small growth in Earnings Per Share. The EPS has been growing by 5.97% on average per year.
The Revenue has grown by 12.88% in the past year. This is quite good.
The Revenue has been growing slightly by 7.43% on average over the past years.
EPS 1Y (TTM)17.26%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%21.13%
Revenue 1Y (TTM)12.88%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%9.43%
3.2 Future
1AMGN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.13% yearly.
Based on estimates for the next years, 1AMGN will show a small growth in Revenue. The Revenue will grow by 3.12% on average per year.
EPS Next Y8.45%
EPS Next 2Y5.44%
EPS Next 3Y4.87%
EPS Next 5Y4.13%
Revenue Next Year7.54%
Revenue Next 2Y4.58%
Revenue Next 3Y3.91%
Revenue Next 5Y3.12%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 15.57 indicates a correct valuation of 1AMGN.
1AMGN's Price/Earnings ratio is rather cheap when compared to the industry. 1AMGN is cheaper than 89.33% of the companies in the same industry.
When comparing the Price/Earnings ratio of 1AMGN to the average of the S&P500 Index (25.89), we can say 1AMGN is valued slightly cheaper.
1AMGN is valuated correctly with a Price/Forward Earnings ratio of 15.40.
1AMGN's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1AMGN is cheaper than 93.33% of the companies in the same industry.
1AMGN is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.59, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.57 | ||
| Fwd PE | 15.4 |
4.2 Price Multiples
1AMGN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 1AMGN is cheaper than 82.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1AMGN is valued cheaply inside the industry as 90.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.05 | ||
| EV/EBITDA | 12.48 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1AMGN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of 1AMGN may justify a higher PE ratio.
PEG (NY)1.84
PEG (5Y)2.61
EPS Next 2Y5.44%
EPS Next 3Y4.87%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.22%, 1AMGN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 11.17, 1AMGN pays a better dividend. On top of this 1AMGN pays more dividend than 97.33% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, 1AMGN pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.22% |
5.2 History
On average, the dividend of 1AMGN grows each year by 9.41%, which is quite nice.
Dividend Growth(5Y)9.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
36.49% of the earnings are spent on dividend by 1AMGN. This is a low number and sustainable payout ratio.
1AMGN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP36.49%
EPS Next 2Y5.44%
EPS Next 3Y4.87%
BIT:1AMGN (11/12/2025, 7:00:00 PM)
293.45
+36.9 (+14.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners84.15%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap157.98B
Revenue(TTM)34.92B
Net Income(TTM)6.62B
Analysts72
Price Target274.32 (-6.52%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.22% |
Yearly Dividend7.79
Dividend Growth(5Y)9.41%
DP36.49%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.69%
Min EPS beat(2)11.64%
Max EPS beat(2)11.73%
EPS beat(4)4
Avg EPS beat(4)8.21%
Min EPS beat(4)2.49%
Max EPS beat(4)11.73%
EPS beat(8)7
Avg EPS beat(8)4.35%
EPS beat(12)10
Avg EPS beat(12)3.9%
EPS beat(16)14
Avg EPS beat(16)4.02%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.84%
Max Revenue beat(2)0.68%
Revenue beat(4)2
Avg Revenue beat(4)-0.49%
Min Revenue beat(4)-2.15%
Max Revenue beat(4)0.68%
Revenue beat(8)2
Avg Revenue beat(8)-1.11%
Revenue beat(12)3
Avg Revenue beat(12)-0.9%
Revenue beat(16)4
Avg Revenue beat(16)-0.92%
PT rev (1m)-2.09%
PT rev (3m)-2.09%
EPS NQ rev (1m)-6.26%
EPS NQ rev (3m)-6.26%
EPS NY rev (1m)1.2%
EPS NY rev (3m)1.2%
Revenue NQ rev (1m)0.71%
Revenue NQ rev (3m)0.71%
Revenue NY rev (1m)1.12%
Revenue NY rev (3m)1.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.57 | ||
| Fwd PE | 15.4 | ||
| P/S | 5.23 | ||
| P/FCF | 16.05 | ||
| P/OCF | 15.21 | ||
| P/B | 24.6 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.48 |
EPS(TTM)18.85
EY6.42%
EPS(NY)19.05
Fwd EY6.49%
FCF(TTM)18.28
FCFY6.23%
OCF(TTM)19.29
OCFY6.57%
SpS56.07
BVpS11.93
TBVpS-57.58
PEG (NY)1.84
PEG (5Y)2.61
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.53% | ||
| ROE | 89.11% | ||
| ROCE | 16.21% | ||
| ROIC | 14.12% | ||
| ROICexc | 16.03% | ||
| ROICexgc | 59.12% | ||
| OM | 31.3% | ||
| PM (TTM) | 18.96% | ||
| GM | 69.71% | ||
| FCFM | 32.61% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
ROICexc(3y)15.77%
ROICexc(5y)17.27%
ROICexgc(3y)75.76%
ROICexgc(5y)77.1%
ROCE(3y)14.97%
ROCE(5y)16.28%
ROICexgc growth 3Y3.26%
ROICexgc growth 5Y-18.2%
ROICexc growth 3Y-8.67%
ROICexc growth 5Y-7.85%
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
F-Score8
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.24 | ||
| Debt/FCF | 4.94 | ||
| Debt/EBITDA | 3.25 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.72% | ||
| Profit Quality | 172.01% | ||
| Current Ratio | 1.31 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | N/A |
F-Score8
WACC9.43%
ROIC/WACC1.5
Cap/Depr(3y)24.77%
Cap/Depr(5y)23.42%
Cap/Sales(3y)3.59%
Cap/Sales(5y)3.31%
Profit Quality(3y)165.92%
Profit Quality(5y)155.23%
High Growth Momentum
Growth
EPS 1Y (TTM)17.26%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%21.13%
EPS Next Y8.45%
EPS Next 2Y5.44%
EPS Next 3Y4.87%
EPS Next 5Y4.13%
Revenue 1Y (TTM)12.88%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%9.43%
Revenue Next Year7.54%
Revenue Next 2Y4.58%
Revenue Next 3Y3.91%
Revenue Next 5Y3.12%
EBIT growth 1Y75.18%
EBIT growth 3Y1.84%
EBIT growth 5Y-0.13%
EBIT Next Year39.98%
EBIT Next 3Y10.33%
EBIT Next 5Y5.65%
FCF growth 1Y17.55%
FCF growth 3Y7.44%
FCF growth 5Y4.03%
OCF growth 1Y11.23%
OCF growth 3Y7.45%
OCF growth 5Y4.66%
AMGEN INC / 1AMGN.MI FAQ
Can you provide the ChartMill fundamental rating for AMGEN INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1AMGN.MI.
Can you provide the valuation status for AMGEN INC?
ChartMill assigns a valuation rating of 6 / 10 to AMGEN INC (1AMGN.MI). This can be considered as Fairly Valued.
How profitable is AMGEN INC (1AMGN.MI) stock?
AMGEN INC (1AMGN.MI) has a profitability rating of 7 / 10.
What is the valuation of AMGEN INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for AMGEN INC (1AMGN.MI) is 15.57 and the Price/Book (PB) ratio is 24.6.
What is the financial health of AMGEN INC (1AMGN.MI) stock?
The financial health rating of AMGEN INC (1AMGN.MI) is 3 / 10.